
Italy urged to address almost €1 billion rise in generics’ production cost
The sharp rise of generic drugs’ production costs on the back of high inflation has caused the Italian government severe headaches, while the industry describes an “unsustainable” situation which could negatively impact patients. Inflation, combined with …